Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

The research helps understand how finasteride works and aids drug development.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

JAK inhibitors are effective for long-term management of alopecia areata.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Persistent ED in Propecia users is not due to abnormal blood flow.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Baricitinib is safer than methotrexate for treating severe alopecia areata.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.